526445 (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE revises price bands for 32 equity scrips effective April 16, 2026, with bands ranging from 2% to 20% across various listed companies. | |||||||||||||||
BSE revises price bands for 32 equity scrips effective April 16, 2026, with bands ranging from 2% to 20% across various listed companies.
| |||||||||||||||
BSE notifies trading members that Indrayani Biotech Ltd has fixed April 28, 2026 as the record date for a rights issue offering 5 equity … | |||||||||||||||
BSE notifies trading members that Indrayani Biotech Ltd has fixed April 28, 2026 as the record date for a rights issue offering 5 equity shares for every 7 held at Rs. 15 per share. Shares will trade on an ex-rights basis effective April 28, 2026.
| |||||||||||||||
BSE has revised price bands for 30+ scrips effective April 13, 2026, with bands ranging from 2% to 20% across equity segment securities. | |||||||||||||||
BSE has revised price bands for 30+ scrips effective April 13, 2026, with bands ranging from 2% to 20% across equity segment securities.
| |||||||||||||||
BSE received clarifications from 60 listed companies regarding significant price/volume movement observed in their scrips. Replies are … | |||||||||||||||
BSE received clarifications from 60 listed companies regarding significant price/volume movement observed in their scrips. Replies are awaited from a few additional companies.
| |||||||||||||||